Recursion Pharmaceuticals stockholders elect directors, approve exec comp, ratify auditor at 2025 meeting

RECURSION PHARMACEUTICALS, INC.

Elected Zachary Bogue (242.3M for, 4.0M withheld), Zavain Dar (203.3M for, 42.9M withheld), Robert Hershberg (233.5M for, 12.8M withheld) as Class I directors.
Advisory resolution to approve executive compensation approved with 239.9M for, 3.2M against, 3.1M abstain, 93.4M broker non-votes.
Ratification of PwC as independent auditor for FY2025 approved with 334.6M for, 2.0M against, 3.1M abstain.

item 5.07

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.